The incidence of drug-related liability claims is discussed, and data from a number of studies in this area are reviewed.
Drug categories that appear to cause the greatest problems are hormones, anticoagulants, adrenal steroids, and antibiotics. Focusing attention on these categories may enable the pharmacist to function as a liability-reducing factor in the institutional setting.
KeysPW. Drug-use review and risk management. Am J Hosp Pharm1981; 38: 1533–4.
2.
ZellmerWA. Can pharmacists prevent drug-induced illness in hospitals?. Am J Hosp Pharm1981; 38: 637.
3.
CowenDL. The colonial and revolutionary heritage of pharmacy in America. VI: The separation of pharmacy from medicine. PA Pharm1976; 57: 7.
4.
YoungWWBellJEBouchardVE. Clinical pharmacy services: Prognostic criteria for selective patient monitoring, part I. Am J Hosp Pharm1974; 31: 562–8.
5.
WissenbergerE. Hospital malpractice liability claims: the INA experience. Philadelphia: Insurance Company of North America, 1972: 26–36,50,56,58.
6.
McDonnellTCGaudiosiTS. Surveillance and control of hospital drug distribution systems: Observations of hospital malpractice loss control specialists. Hosp Pharm1977; 12: 529, 532–3.
7.
Summary of drug-related malpractice claims. Malpractice Digest1979;May/June:3.
8.
CurranWJ. Malpractice claims: New data and new trends. N Engl J Med1979; 300: 26–7.
9.
MikolajPJ. Hospital association determines nature of closed claims in state. Hospitals1978; 52(Feb 1):53–6.
10.
BrownGC. Medication errors: A case study. Hospitals1979; 55(Oct 16):61–265.
11.
SteelKGertmanPMCrescengiC. Iatrogenic illness on a general medical service at a university hospital. N Engl J Med1981; 304: 638–42.
12.
RudovMHMyersTIMirabellaA. Medical malpractice insurance claims files closed in 1970. Appendix to the Report of the Secretary's Commission on Medical Malpractice. Washington, DC: Department of Health, Education and Welfare, 1973 (DHEW publication no. [OS] 73–89).
13.
TroutME. The malpractice crisis today: II. Medical-legal implications of prescribing. Hosp Form1976; 11: 89–90.
14.
PocinckiLSDoggerSJSchwartzBP. The incidence of iatrogenic injuries. Appendix to the Report of the Secretary's Commission on Medical Malpractice. Washington, DC: Department of Health, Education and Welfare, 1973 (DHEW publication no. [OS] 73–89).
15.
Report of the Secretary's Commission on Medical Malpractice. Washington, DC: Department of Health, Education and Welfare, 1973 (DHEW publication no. [OS] 73–89).
16.
Malpractice claims survey. Milwaukee, WI: National Association of Insurance Commissioners, 1976(Sept):35.
17.
MillsDH, ed. Report on the medical insurance feasibility study. San Francisco: Sutter Publications, 1977: 71–5.
18.
HirshHLWhiteER. The pathological anatomy of medical malpractice claims. Legal Aspects Med Pract1978; 6(Jan):9–16.
19.
HirshHLWhiteER. These MD-JDs say: “Prophylaxis beats malpractice!”PA Med1977; 80(Nov):23–6.
20.
Medical malpractice claims: a synopsis of the HEW/industry study of medical malpractice insurance claims. Washington, DC: Public Health Service and Health Care Financing Administration, 1978.
21.
FinkJLIII. Pharmacists as a liability-reducing factor. Am J Hosp Pharm1982; 39: 1544–6.
